Chronic Hepatitis B Infection: Patient Guidance

Area of Science:

• Hepatology
• Public Health
• Patient Education

Background:

• Chronic hepatitis B (CHB) is a major global cause of cirrhosis and liver cancer.
• Awareness of CHB infection is low, with less than 20% of infected individuals knowing their status.
• Many infected individuals do not receive adequate assessment and management for CHB.

Purpose of the Study:

• To provide patient guidance for individuals at risk of or living with chronic hepatitis B.
• To summarize updated knowledge on CHB assessment, management, and treatment.
• To empower patients with CHB to actively participate in their healthcare.

Main Methods:

• Development of a patient guidance document through collaboration with clinicians, scientists, patients, and patient representatives.
• Summarization of current scientific knowledge and clinical recommendations for CHB.
• Inclusion of essential measures for CHB management and prevention of transmission.

Main Results:

• Highlights the availability of safe and effective treatments for CHB in many regions.
• Recommends essential measures including lifestyle adjustments, coinfection screening, comorbidity management, fibrosis assessment, HBV transmission prevention, and liver cancer surveillance.
• Notes recent advancements in CHB treatment paradigms and new drug development.

Conclusions:

• Increased patient understanding of CHB can lead to more active participation in disease management.
• Timely assessment and management are vital for individuals with CHB to prevent complications like cirrhosis and hepatocellular carcinoma.
• This guidance aims to inform and empower individuals affected by chronic hepatitis B.